Navigation Links
InfraReDx's LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology
Date:3/10/2010

C2010Home.aspx">http://acc10.acc.org/Pages/ACC2010Home.aspx.

About InfraReDx, Inc.

InfraReDx, Inc., headquartered in Burlington, Massachusetts, is a privately-funded medical device company founded in 1998 and focused on intravascular characterization of disease in the coronary arteries. InfraReDx is the maker of the LipiScan™ system, a novel near-infrared (NIR) spectroscopy catheter that can detect the lipid core coronary plaques suspected to cause most heart attacks and known to complicate stenting procedures. For more information, visit www.infraredx.com.  

    
    
    Contacts: 
    Media:
    Keri Mattox
    Pure Communications, Inc.
    215.791.0105
    keri@purecommunicationsinc.com
    
    Company:
    Jim Dillon
    Vice President of Sales and Marketing
    781.345.9679
    
SOURCE InfraReDx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
2. First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System
3. InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundations (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting
4. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
5. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
8. Surgery More Likely Than Angioplasty to Relieve Pain for Patients With Coronary Artery Disease
9. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
10. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
11. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... BURLINGTON, Mass. , July 31, 2014 ... healthcare funding changes brought about by the ... both reimbursement and prescribing of pharmaceutical therapies. ... (MCOs) cover beneficiaries through new regulations and ... is occurring in the health exchanges—state-based marketplaces ...
(Date:7/31/2014)... 2014 Hovione today announced that its ... successfully passed a pre-approval inspection by the US Food and ... the FDA Consumer Safety Officer, Ms. Britanny Terhar , ... July and concluded on the 25 th . The ... and guidelines of Good Manufacturing Practices (GMP) and no Form ...
(Date:7/31/2014)... announces the list of stocks featured in the Analyst Blog. ... news and events impacting stocks and the financial markets. Stocks ... - Free Report ), Gilead (Nasdaq: GILD - Free ... ), AbbVie (NYSE: ABBV - Free Report ) and ... Today, Zacks is promoting its ,Buy, stock recommendations. Get ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6
... N.J. , Aug. 4 ... Co., Ltd, (collectively, "Daiichi Sankyo") have reached an agreement ... settle their patent litigation involving Apotex,s challenge to Daiichi ... "the ,821 patent") covering Evoxac® (cevimeline HCl).  Under the ...
... Cardica, Inc. (Nasdaq: CRDC ) today announced that it will release ... Tuesday, August 17, 2010 , after the markets close. Cardica,s management will host a conference ... update on the company,s business. , , , ... , , , ...
Cached Medicine Technology:Daiichi Sankyo Settled Patent Litigation for Evoxac® 2Cardica to Announce Fiscal 2010 Fourth Quarter and Year End Financial Results on Tuesday, August 17, 2010 2
(Date:7/31/2014)... News) -- With the World Health Organization reporting that ... has risen to 729, the U.S. Centers for ... warning for,the region. The "Level 3 travel advisory" ... -- Guinea, Liberia and Sierra Leone -- be avoided. ... in West Africa," CDC Director Dr. Tom Frieden told ...
(Date:7/31/2014)... N.Y. Athletes and others reporting cognitive difficulties after ... a concussion. But is it really a concussion? A ... finds that many of the same symptoms are common ... balance system, known collectively as cervical/vestibular injuries. , The ... patients some of whom were professional athletes ...
(Date:7/31/2014)... Joseph M. Lee, M.D., M.S., R.P.V.I, ... a leading provider of quality cardiovascular and internal medicine ... Dr. Lee is a board certified cardiologist with a ... addition to his position at CDHV, Dr. Lee is ... Columbia University Medical Center. Dr. Lee is board certified ...
(Date:7/31/2014)... 31, 2014 Insight Accelerator Labs member ... A round of investment for $4.6 million to fund ... collecting vital signs. The company joined Insight Accelerator ... fruition with the help of Insight development teams. ... for launching the Accelerator,” says Steve McPhilliamy, Executive Director ...
(Date:7/31/2014)... July 31, 2014 Bedford Commons ... firm Innerspire: Brand ReEnergizers to do what ... how we connect with the community all while still ... area practice, which caters to women’s health needs for ... and total women focused care ( Gynecology ), worked ...
Breaking Medicine News(10 mins):Health News:CDC Issues Travel Warning as West Africa Ebola Outbreak Worsens 2Health News:Is it really a concussion? Symptoms overlap with neck injuries so diagnosis is tough call 2Health News:Is it really a concussion? Symptoms overlap with neck injuries so diagnosis is tough call 3Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 2Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 3Health News:Insight Accelerator Labs Advances Member Toward Commercialization 2Health News:Insight Accelerator Labs Advances Member Toward Commercialization 3Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 2Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 3Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 4
... may further damage already weakened vessels , , THURSDAY, March 6 ... hemorrhagic stroke already faced by people with high blood pressure, ... people, average age 47, who took part in the Asia ... the participants were smokers at the start of the study. ...
... PARAMUS, N.J., March 6 Smart Balance Inc. ... http://www.smartbalance.com on,March 14, 2008, at 9:30 ... which will be issued at approximately 7 a.m. ... listen-only mode. The webcast is also,available through the ...
... March 6 Empire Blue Cross Blue Shield has,been ... first,brought this issue to our attention., We were ... have been diligent in our efforts to determine whether ... prepared to share,data with the Attorney General,s office in ...
... CREEK, Calif., March 6 Longs Drug,Stores Corporation (NYSE: LDG ) today reported preliminary total retail drug,store ... million in the comparable period,a year ago., , (Dollars in millions) ... Total retail drug store sales ... period ...
... 6 Carriage Services, Inc.,(NYSE: CSV ) today confirmed ... that was previously announced on February 4, 2008.,Highlight results of ... 2006 were as follows:, -- Revenues of $167.8 ... million for 2006. -- Total Field EBITDA of $61.6 ...
... the nation is once again readying itself for losing an ... This is a shock not only to those of ... all levels of the economy, from the individual to the ... Labor Economics, Cues for Timing and Coordination: Latitude, Letterman, and ...
Cached Medicine News:Health News:Smoking Boosts 'Bleeding' Stroke Risk in Those With High Blood Pressure 2Health News:Smart Balance to Host Webcast/Conference Call on 2007 Fourth-Quarter and Full-Year Results 2Health News:Longs Reports Preliminary February Retail Drug Store Sales 2Health News:Carriage Services Reports 2007 Full Year Results 2Health News:Carriage Services Reports 2007 Full Year Results 3Health News:Carriage Services Reports 2007 Full Year Results 4Health News:Carriage Services Reports 2007 Full Year Results 5Health News:Carriage Services Reports 2007 Full Year Results 6Health News:Carriage Services Reports 2007 Full Year Results 7Health News:Carriage Services Reports 2007 Full Year Results 8Health News:Carriage Services Reports 2007 Full Year Results 9Health News:Carriage Services Reports 2007 Full Year Results 10Health News:Carriage Services Reports 2007 Full Year Results 11Health News:Carriage Services Reports 2007 Full Year Results 12Health News:Carriage Services Reports 2007 Full Year Results 13Health News:Carriage Services Reports 2007 Full Year Results 14Health News:Carriage Services Reports 2007 Full Year Results 15Health News:Carriage Services Reports 2007 Full Year Results 16Health News:Carriage Services Reports 2007 Full Year Results 17Health News:Carriage Services Reports 2007 Full Year Results 18Health News:Carriage Services Reports 2007 Full Year Results 19Health News:Carriage Services Reports 2007 Full Year Results 20Health News:Carriage Services Reports 2007 Full Year Results 21Health News:Carriage Services Reports 2007 Full Year Results 22Health News:Carriage Services Reports 2007 Full Year Results 23Health News:Carriage Services Reports 2007 Full Year Results 24Health News:Carriage Services Reports 2007 Full Year Results 25Health News:Carriage Services Reports 2007 Full Year Results 26Health News:Carriage Services Reports 2007 Full Year Results 27Health News:Carriage Services Reports 2007 Full Year Results 28Health News:Carriage Services Reports 2007 Full Year Results 29Health News:Early to bed early to rise ... depends on the TV schedule in your time zone 2Health News:Early to bed early to rise ... depends on the TV schedule in your time zone 3
... the state of the art product for ... articular surfaces does not restrict natural movement, ... a wide area of contact between the ... of cement create a homogeneous cement mantle ...
... The TC-PLUS Solution tricompartmental total knee ... with knee arthroplasty. State-of-the-art design and manufacturing ... achieve optimum biomechanical function as well as ... polyethylene tibial insert to keep wear to ...
The RT-PLUS Solution is an axially supported rotation knee prosthesis for cemented implantation. The modern design allows extremely sparing resections. The components exhibit an anatomical geometry t...
... System is a long term, quality solution ... in both posterior stabilized and anatomically correct ... provides the flexibility needed to address patients' ... of identification keeps the user in mind ...
Medicine Products: